Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Vail

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Veterinary and Comparative Oncology|January 11, 2021
Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and catsAmy K LeBlanc, Matthew Atherton, R Timothy Bentley, et al.
Veterinary Immunology and Immunopathology|December 6, 2023
Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogsJenna H Burton, Stephen Albert Johnston, David M Vail, et al.
Frontiers in Veterinary Science|December 27, 2021
Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus ProposalMichael Willmann, Vilma Yuzbasiyan-Gurkan, Laura Marconato, et al.
Plos One|April 30, 2015
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional StudyCheryl A London, Heather L Gardner, Tamra Mathie, et al.
Frontiers in Immunology|November 10, 2025
Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcomaRobert B Rebhun, Sylvia M Cruz, Daniel York, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2Nicola J Mason, Laura Selmic, Audrey Ruple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 DogsAmy K LeBlanc, Christina N Mazcko, Aswini Cherukuri, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Veterinary and Comparative Oncology|January 11, 2021
Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and catsAmy K LeBlanc, Matthew Atherton, R Timothy Bentley, et al.
Veterinary Immunology and Immunopathology|December 6, 2023
Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogsJenna H Burton, Stephen Albert Johnston, David M Vail, et al.
Frontiers in Veterinary Science|December 27, 2021
Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus ProposalMichael Willmann, Vilma Yuzbasiyan-Gurkan, Laura Marconato, et al.
Plos One|April 30, 2015
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional StudyCheryl A London, Heather L Gardner, Tamra Mathie, et al.
Frontiers in Immunology|November 10, 2025
Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcomaRobert B Rebhun, Sylvia M Cruz, Daniel York, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2Nicola J Mason, Laura Selmic, Audrey Ruple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 DogsAmy K LeBlanc, Christina N Mazcko, Aswini Cherukuri, et al.
Pageof 8